AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a significant growth in short interest in August. As of August 14th, there was short interest totaling 183,426 shares, a growth of 109.3% from the July 30th total of 87,636 shares. Currently, 3.6% of the company’s stock are short sold. Based on an average daily volume of 2,836,488 shares, the days-to-cover ratio is currently 0.1 days.

AquaBounty Technologies Price Performance

Shares of AquaBounty Technologies stock opened at $1.25 on Monday. The firm has a market cap of $6.44 million, a price-to-earnings ratio of -1.52 and a beta of 1.39. The company’s 50-day simple moving average is $1.10 and its 200-day simple moving average is $1.00. AquaBounty Technologies has a 52-week low of $0.77 and a 52-week high of $2.95.

AquaBounty Technologies (NASDAQ:AQB) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.26) EPS for the quarter.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded shares of AquaBounty Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 12th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

Institutional Trading of AquaBounty Technologies

Several large investors have recently modified their holdings of AQB. Two Sigma Investments LP acquired a new position in AquaBounty Technologies in the 3rd quarter valued at $84,000. BlackRock Inc. purchased a new stake in shares of AquaBounty Technologies in the second quarter worth about $51,000. Finally, Renaissance Technologies LLC grew its holdings in AquaBounty Technologies by 311.9% during the 4th quarter. Renaissance Technologies LLC now owns 121,585 shares of the company’s stock valued at $113,000 after purchasing an additional 92,065 shares in the last quarter. 8.92% of the stock is currently owned by institutional investors and hedge funds.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.